IP Library › Assignment 051735/0725
Patent Assignment
Reel/Frame 051735/0725

Assignment of Assignor's Interest

Recorded: 2020-01-29 Pages: 3
Assignor
NOVOCURE (ISRAEL) LTD.
Executed: 2019-12-05
Assignee
NOVOCURE GMBH
6 PARK, ROOT D4, 6039, SWITZERLAND
Covered Properties (4)
Methods for Reducing Viability of Cancer Cells by Activation of the Sting Pathway with Ttfields
Application: 16/673,246 →
Publication: US 2021/0069503
Inhibiting Prostaglandin E Receptor 3 Resensitizes Resistant Cells to TTFields
Application: 62/826,078 →
Inhibiting Prostaglandin E Receptor 3 Resensitizes Resistant Cells to TTFields and Prevents Cells from Developing Resistance to TTFields
Application: 62/849,535 →
Methods for Reducing Viability of Cancer Cells by Activation of the STING Pathway with TTFields
Application: 62/898,290 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 11, 2019
From: TRAN, DAVID; LE, SON BANG; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 050342/0177 →
Assignment of Assignor's Interest Sep 11, 2019
From: TRAN, DAVID; LE, SON BANG; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 050342/0240 →
Assignment of Assignor's Interest Sep 18, 2019
From: TRAN, DAVID; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 050415/0723 →
Assignment of Assignor's Interest Jan 29, 2020
From: TRAN, DAVID; CHEN, DONGJIANG
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 051659/0319 →
Assignment of Assignor's Interest Jan 29, 2020
From: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
To: NOVOCURE (ISRAEL) LTD.
Reel/Frame 051659/0531 →
Security Interest Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
Release of Security Interest Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
Patent Security Agreement May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →